← Open Payments lookup

TRACY YAGER: Open Payments

NPI 1689068611 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,513 in 58 payments from 17 companies in 2025. Trend: 2023 $2,097 · 2024 $1,193 · 2025 $1,513

Food & beverage: $1,382Education: $131
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.10$278
AstraZeneca Pharmaceuticals LP8$195
CSL Behring8$178
ARS Pharmaceuticals Operations, Inc.6$120
PFIZER INC.4$104
SANOFI-AVENTIS U.S. LLC1$99
Takeda Pharmaceuticals U.S.A., Inc.3$93
GENZYME CORPORATION2$83
Amgen Inc.4$71
GlaxoSmithKline, LLC.3$68

Products named: DUPIXENT, TEZSPIRE, NEFFY, Andembry, CIBINQO, Hizentra, TAKHZYRO, EBGLYSS.

Industry payments across MD — which companies pay providers there.